A
Ashfaq Shuaib
Researcher at University of Alberta
Publications - 438
Citations - 25002
Ashfaq Shuaib is an academic researcher from University of Alberta. The author has contributed to research in topics: Stroke & Ischemia. The author has an hindex of 63, co-authored 394 publications receiving 21280 citations. Previous affiliations of Ashfaq Shuaib include University of New South Wales & Hamad Medical Corporation.
Papers
More filters
Journal ArticleDOI
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
Mayank Goyal,Muneer Eesa,John Thornton,Denis-Claude Roy,Dar Dowlatshahi,Ashfaq Shuaib,D. Tampieri,David Williams,H. Choe,Brian T. Jankowitz,Michael Kelly,Guillermo Linares,Jai Jai Shiva Shankar,Alain Weill,Suresh Subramaniam,Abstr Act +15 more
TL;DR: In this paper, the authors evaluated rapid endovascular treatment in addition to standard care in patients with acute ischemic stroke with a small infarct core, a proximal intracranial arterial occlusion, and moderate-to-good collateral circulation.
Journal ArticleDOI
Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis
Jeffrey L. Saver,Mayank Goyal,Aad van der Lugt,Bijoy K Menon,Charles B. L. M. Majoie,Diederik W.J. Dippel,Bruce C.V. Campbell,Raul G Nogueira,Andrew M. Demchuk,Alejandro Tomasello,Pere Cardona,Thomas Devlin,Donald Frei,Richard du Mesnil de Rochemont,Olvert A. Berkhemer,Tudor G Jovin,Adnan H. Siddiqui,Wim H. van Zwam,Stephen M. Davis,Carlos Castaño,Biggya L. Sapkota,Puck S.S. Fransen,Carlos A. Molina,Robert J. van Oostenbrugge,Ángel Chamorro,Hester F. Lingsma,Frank L. Silver,Geoffrey A. Donnan,Ashfaq Shuaib,Scott Brown,Bruce Stouch,Peter Mitchell,Antoni Dávalos,Yvo B.W.E.M. Roos,Michael D. Hill +34 more
TL;DR: The period in which endovascular thrombectomy is associated with benefit, and the extent to which treatment delay is related to functional outcomes, mortality, and symptomatic intracranial hemorrhage are characterized are characterized.
Journal ArticleDOI
Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.
Gregory W. Albers,Vincent Thijs,Lawrence R. Wechsler,Stephanie Kemp,Gottfried Schlaug,Elaine Skalabrin,Roland Bammer,Wataru Kakuda,Maarten G Lansberg,Ashfaq Shuaib,William Coplin,Scott Hamilton,Michael E. Moseley,Michael P. Marks +13 more
TL;DR: For stroke patients treated 3 to 6 hours after onset, baseline MRI findings can identify subgroups that are likely to benefit from reperfusion therapies and can potentially identify sub groups that are unlikely to benefit or may be harmed.
Journal ArticleDOI
Atrial Fibrillation in Patients with Cryptogenic Stroke
David J. Gladstone,Melanie Spring,Paul Dorian,Val Panzov,Kevin E. Thorpe,Haris M. Vaid,Andreas Laupacis,Robert Côté,Mukul Sharma,John A. Blakely,Ashfaq Shuaib,Vladimir Hachinski,Shelagh B. Coutts,Demetrios J. Sahlas,Phil Teal,Samuel Yip,J. David Spence,Brian Buck,Steve Verreault,Leanne K. Casaubon,Andrew M Penn,Daniel Selchen,Albert Y. Jin,David Howse,Manu Mehdiratta,Karl Boyle,Richard I. Aviv,Moira K. Kapral,Muhammad Mamdani +28 more
TL;DR: Noninvasive ambulatory ECG monitoring for a target of 30 days significantly improved the detection of atrial fibrillation by a factor of more than five and nearly doubled the rate of anticoagulant treatment, as compared with the standard practice of short-duration ECG Monitoring.
Journal Article
Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study) : a prospective population-based sequential comparison. Commentery
Naeem Dean,Ashfaq Shuaib,Peter M. Rothwell,Matthew F. Giles,Arvind Chandratheva,Lars Marquardt,Olivia C. Geraghty,Jessica Redgrave,Caroline E. Lovelock,L E Binney,Linda M. Bull,Fiona C. Cuthbertson,Sarah J.V. Welch,Shelley Bosch,Faye Carasco-Alexander,Louise E. Silver,Sergei A. Gutnikov,Ziyah Mehta +17 more
TL;DR: Early initiation of existing treatments after TIA or minor stroke was associated with an 80% reduction in the risk of early recurrent stroke, and early treatment did not increase therisk of intracerebral haemorrhage or other bleeding.